NCT07738653

Brief Summary

This research project aims to investigate whether participation in a 5-day meditation retreat is associated with changes in biomechanical gait parameters in experienced meditators. Walking is a complex motor function that integrates cognitive, sensory, and neuromuscular processes, and alterations in gait have been linked to neurological, psychological, and emotional functioning. Recent advances in wearable sensor technology enable precise assessment of gait characteristics, including stance and swing phases, foot-rocker timing, acceleration, and joint kinematics, providing objective measures of motor performance. Mindfulness has consistently demonstrated beneficial effects on psychological well-being, emotion regulation, and body awareness, and growing evidence suggests that emotional states influence motor behavior, including gait. Furthermore, mindfulness-based interventions have shown promising effects on motor symptoms in some clinical populations, although the underlying mechanisms remain poorly understood. Meditation retreats, which combine intensive mindfulness practice with a distraction-free environment, have been associated with sustained improvements in stress, anxiety, quality of life, and neuroplasticity-related processes. However, despite increasing interest in mind-body interventions, no published studies have specifically examined the effects of meditation retreats on gait biomechanics. This pilot study therefore seeks to address this knowledge gap by evaluating changes in gait and foot-strike biomechanics before and after a 5-day meditation retreat using wearable gait analysis technology. In addition, the study will explore the relationship between changes in biomechanical gait variables and participants' levels of mindfulness and quality of life. The findings are expected to provide preliminary evidence on the potential motor effects of intensive meditation practice and contribute to a better understanding of the interaction between mindfulness, body awareness, and locomotor function in healthy individuals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 18, 2023

Completed
5 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 23, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 23, 2023

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

July 21, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 31, 2026

Completed
Last Updated

July 31, 2026

Status Verified

July 1, 2026

Enrollment Period

5 days

First QC Date

July 21, 2026

Last Update Submit

July 27, 2026

Conditions

Outcome Measures

Primary Outcomes (12)

  • Biomechanical Variables

    Inertial sensors: These sensors consist of accelerometers and gyroscopes that enable the estimation of foot movements. Electronic baropodometer: This is a device comprising a platform with digital sensors designed to assess the points of maximum pressure on the foot whilst stationary, as well as to analyse the feet whilst in motion, obtaining data on pressure, rotation and displacement.

    Baseline

  • 15-item Five Facet Mindfulness Questionnaire (FFMQ-15)

    The FFMQ is a test comprising 39 items, which measures the general tendency to practise mindfulness based on five skills: Observation, Description, Mindful Action, Non-judgement and Non-reactivity. This scale is valid and reliable, with a Cronbach's alpha coefficient of 0.84. Total scores range from 15 to 75, with higher scores indicating greater levels of mindfulness.

    Baseline

  • Generalized Anxiety Disorder-7 (GAD-7)

    Generalised Anxiety Disorder Scale (GAD-7): The GAD-7 is a tool that demonstrates adequate indicators of validity and reliability. It is an excellent, reliable, easy and quick-to-use tool for detecting symptoms of generalised anxiety; its internal consistency yielded a Cronbach's alpha of 0.88. Total scores range from 0 to 21, with higher scores indicating greater anxiety symptom severity. Scores of 0-4 indicate minimal anxiety, 5-9 mild anxiety, 10-14 moderate anxiety, and 15-21 severe anxiety.

    Baseline

  • Patient Health Questionnaire-9 (PHQ-9)

    Patient Health Questionnaire (PHQ-9): The PHQ-9 is a nine-item self-report measure that evaluates the presence of depressive symptoms based on the DSM-IV criteria for major depressive episode. This questionnaire demonstrates good internal consistency, with a Cronbach's alpha of 0.80. Total scores range from 0 to 27, with higher scores indicating greater depressive symptom severity. Scores of 0-4 indicate minimal depression, 5-9 mild depression, 10-14 moderate depression, 15-19 moderately severe depression, and 20-27 severe depression.

    Baseline

  • 12-Item Short Form Health Survey (SF-12)

    The SF-12 is a generic measure of health-related quality of life that evaluates physical, mental, and social health. It is a shortened version of the SF-36 and assesses the same eight health domains: Physical Functioning, Role Physical, Bodily Pain, General Health, Vitality, Social Functioning, Role Emotional, and Mental Health. Domain scores are transformed to a 0-100 scale, where 0 represents the worst possible health status and 100 the best possible health status. Higher scores indicate better perceived health-related quality of life. The SF-12 also provides Physical Component Summary (PCS) and Mental Component Summary (MCS) scores.

    Baseline

  • Visual Analogue Scale (VAS)

    The Visual Analogue Scale (VAS) is a single-item self-report measure used to assess the intensity of emotional states. Each emotion is rated on a 0-10 scale, with higher scores indicating greater emotional intensity. In this study, the VAS was used to assess the intensity of happiness, sadness, anger, surprise, anxiety, relaxation/calm, and vigor/energy. A score of 0 indicates the complete absence of the emotion, whereas a score of 10 indicates the maximum intensity of that emotion.

    Baseline

  • Biomechanical Variables

    Inertial sensors: These sensors consist of accelerometers and gyroscopes that enable the estimation of foot movements. Electronic baropodometer: This is a device comprising a platform with digital sensors designed to assess the points of maximum pressure on the foot whilst stationary, as well as to analyse the feet whilst in motion, obtaining data on pressure, rotation and displacement.

    Up to 5 days

  • 15-item Five Facet Mindfulness Questionnaire (FFMQ-15)

    The FFMQ is a test comprising 39 items, which measures the general tendency to practise mindfulness based on five skills: Observation, Description, Mindful Action, Non-judgement and Non-reactivity. This scale is valid and reliable, with a Cronbach's alpha coefficient of 0.84. Total scores range from 15 to 75, with higher scores indicating greater levels of mindfulness.

    Up to 5 days

  • Generalized Anxiety Disorder-7 (GAD-7)

    Generalised Anxiety Disorder Scale (GAD-7): The GAD-7 is a tool that demonstrates adequate indicators of validity and reliability. It is an excellent, reliable, easy and quick-to-use tool for detecting symptoms of generalised anxiety; its internal consistency yielded a Cronbach's alpha of 0.88. Total scores range from 0 to 21, with higher scores indicating greater anxiety symptom severity. Scores of 0-4 indicate minimal anxiety, 5-9 mild anxiety, 10-14 moderate anxiety, and 15-21 severe anxiety.

    Up to 5 days

  • Patient Health Questionnaire (PHQ-9)

    Patient Health Questionnaire (PHQ-9): The PHQ-9 is a nine-item self-report measure that evaluates the presence of depressive symptoms based on the DSM-IV criteria for major depressive episode. This questionnaire demonstrates good internal consistency, with a Cronbach's alpha of 0.80. Total scores range from 0 to 27, with higher scores indicating greater depressive symptom severity. Scores of 0-4 indicate minimal depression, 5-9 mild depression, 10-14 moderate depression, 15-19 moderately severe depression, and 20-27 severe depression.

    Up to 5 days

  • 12-Item Short Form Health Survey (SF-12)

    The SF-12 is a generic measure of health-related quality of life that evaluates physical, mental, and social health. It is a shortened version of the SF-36 and assesses the same eight health domains: Physical Functioning, Role Physical, Bodily Pain, General Health, Vitality, Social Functioning, Role Emotional, and Mental Health. Domain scores are transformed to a 0-100 scale, where 0 represents the worst possible health status and 100 the best possible health status. Higher scores indicate better perceived health-related quality of life. The SF-12 also provides Physical Component Summary (PCS) and Mental Component Summary (MCS) scores.

    Up to 5 days

  • Visual Analogue Scale (VAS)

    The Visual Analogue Scale (VAS) is a single-item self-report measure used to assess the intensity of emotional states. Each emotion is rated on a 0-10 scale, with higher scores indicating greater emotional intensity. In this study, the VAS was used to assess the intensity of happiness, sadness, anger, surprise, anxiety, relaxation/calm, and vigor/energy. A score of 0 indicates the complete absence of the emotion, whereas a score of 10 indicates the maximum intensity of that emotion.

    Up to 5 days

Secondary Outcomes (10)

  • Gender

    Baseline

  • Age

    Baseline

  • Nationality

    Baseline

  • Current city of residence

    Baseline

  • Cohabitation

    Baseline

  • +5 more secondary outcomes

Study Arms (1)

Meditators in Retreat

EXPERIMENTAL

Meditators participating in a 5-day retreat.

Behavioral: Meditation

Interventions

MeditationBEHAVIORAL

This is a 5-day meditation retreat during which participants take part in various practices.

Meditators in Retreat

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Taking part in the meditation retreat
  • Being able to read and understand the Spanish language
  • Not have been diagnosed with any serious medical or psychiatric conditions
  • Not have been diagnosed with any condition that impairs or alters foot strike or gait

You may not qualify if:

  • Age: \<18 years old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Psychiatry. Miguel Servet University Hospital, Zaragoza, Zaragoza 50009

Zaragoza, Spain

Location

Related Publications (28)

  • Wang S, Zhang C, Xu W. Mindfulness, mortality, disability rates, physical and mental health among the oldest old. Health Psychol. 2023 Oct;42(10):746-755. doi: 10.1037/hea0001315. Epub 2023 Aug 24.

    PMID: 37616101BACKGROUND
  • Verhaeghen P, Aikman SN, Mirabito G. Mindfulness Interventions in Older Adults for Mental Health and Well-Being: A Meta-Analysis. J Gerontol B Psychol Sci Soc Sci. 2025 Mar 12;80(4):gbae205. doi: 10.1093/geronb/gbae205.

    PMID: 39708291BACKGROUND
  • Trinh J, de Vries NM, Chan P, Dekker MCJ, Helmich RC, Bloem BR. The role of lifestyle interventions in symptom management and disease modification in Parkinson's disease. Lancet Neurol. 2026 Jan;25(1):90-102. doi: 10.1016/S1474-4422(25)00305-9. Epub 2025 Oct 15.

    PMID: 41109323BACKGROUND
  • Takakusaki K. Functional Neuroanatomy for Posture and Gait Control. J Mov Disord. 2017 Jan;10(1):1-17. doi: 10.14802/jmd.16062. Epub 2017 Jan 18.

    PMID: 28122432BACKGROUND
  • Sloman L, Berridge M, Homatidis S, Hunter D, Duck T. Gait patterns of depressed patients and normal subjects. Am J Psychiatry. 1982 Jan;139(1):94-7. doi: 10.1176/ajp.139.1.94.

    PMID: 7055284BACKGROUND
  • Schlechta Portella CF, Ghelman R, Abdala V, Schveitzer MC, Afonso RF. Meditation: Evidence Map of Systematic Reviews. Front Public Health. 2021 Dec 2;9:742715. doi: 10.3389/fpubh.2021.742715. eCollection 2021.

    PMID: 34926371BACKGROUND
  • Prakash RS, Whitmoyer P, Aldao A, Schirda B. Mindfulness and emotion regulation in older and young adults. Aging Ment Health. 2017 Jan;21(1):77-87. doi: 10.1080/13607863.2015.1100158. Epub 2015 Nov 4.

    PMID: 26537859BACKGROUND
  • Niedenthal PM. Embodying emotion. Science. 2007 May 18;316(5827):1002-5. doi: 10.1126/science.1136930.

    PMID: 17510358BACKGROUND
  • Mirelman A, Shema S, Maidan I, Hausdorff JM. Gait. Handb Clin Neurol. 2018;159:119-134. doi: 10.1016/B978-0-444-63916-5.00007-0.

    PMID: 30482309BACKGROUND
  • Michalak J, Rohde K, Troje NF. How we walk affects what we remember: gait modifications through biofeedback change negative affective memory bias. J Behav Ther Exp Psychiatry. 2015 Mar;46:121-5. doi: 10.1016/j.jbtep.2014.09.004. Epub 2014 Sep 28.

    PMID: 25310681BACKGROUND
  • Mak TCT, Wong TWL, Ng SSM. The use of mindfulness-based interventions in stroke rehabilitation: A scoping review. Rehabil Psychol. 2023 Aug;68(3):221-234. doi: 10.1037/rep0000505. Epub 2023 Jun 1.

    PMID: 37261753BACKGROUND
  • Lin HW, Tam KW, Kuan YC. Mindfulness or meditation therapy for Parkinson's disease: A systematic review and meta-analysis of randomized controlled trials. Eur J Neurol. 2023 Aug;30(8):2250-2260. doi: 10.1111/ene.15839. Epub 2023 May 21.

    PMID: 37158296BACKGROUND
  • Levine GN, Lange RA, Bairey-Merz CN, Davidson RJ, Jamerson K, Mehta PK, Michos ED, Norris K, Ray IB, Saban KL, Shah T, Stein R, Smith SC Jr; American Heart Association Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Council on Hypertension. Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart Association. J Am Heart Assoc. 2017 Sep 28;6(10):e002218. doi: 10.1161/JAHA.117.002218.

    PMID: 28963100BACKGROUND
  • Lemke MR, Wendorff T, Mieth B, Buhl K, Linnemann M. Spatiotemporal gait patterns during over ground locomotion in major depression compared with healthy controls. J Psychiatr Res. 2000 Jul-Oct;34(4-5):277-83. doi: 10.1016/s0022-3956(00)00017-0.

    PMID: 11104839BACKGROUND
  • Khoury B, Knauper B, Schlosser M, Carriere K, Chiesa A. Effectiveness of traditional meditation retreats: A systematic review and meta-analysis. J Psychosom Res. 2017 Jan;92:16-25. doi: 10.1016/j.jpsychores.2016.11.006. Epub 2016 Nov 18.

    PMID: 27998508BACKGROUND
  • Kang GE, Mickey BJ, McInnis MG, Krembs BS, Gross MM. Motor behavior characteristics in various phases of bipolar disorder revealed through biomechanical analysis: Quantitative measures of activity and energy variables during gait and sit-to-walk. Psychiatry Res. 2018 Nov;269:93-101. doi: 10.1016/j.psychres.2018.08.062. Epub 2018 Aug 17.

    PMID: 30145308BACKGROUND
  • Jinich-Diamant A, Simpson S, Zuniga-Hertz JP, Chitteti R, Schilling JM, Bonds JA, Case L, Chernov AV, Dispenza J, Maree J, Amkie Stahl NE, Licamele M, Fazlalipour N, Devulapalli S, Christov-Moore L, Reggente N, Poirier MA, Moeller-Bertram T, Patel HH. Neural and molecular changes during a mind-body reconceptualization, meditation, and open label placebo healing intervention. Commun Biol. 2025 Nov 6;8(1):1525. doi: 10.1038/s42003-025-09088-3.

    PMID: 41198896BACKGROUND
  • Jin X, Wang L, Liu S, Zhu L, Loprinzi PD, Fan X. The Impact of Mind-body Exercises on Motor Function, Depressive Symptoms, and Quality of Life in Parkinson's Disease: A Systematic Review and Meta-analysis. Int J Environ Res Public Health. 2019 Dec 18;17(1):31. doi: 10.3390/ijerph17010031.

    PMID: 31861456BACKGROUND
  • Homagain A, Ehgoetz Martens KA. Emotional states affect steady state walking performance. PLoS One. 2023 Sep 14;18(9):e0284308. doi: 10.1371/journal.pone.0284308. eCollection 2023.

    PMID: 37708145BACKGROUND
  • He S, Fang W, Wu J, Lv H, Zhang J, Wang T, Huang Y, Li G, Li M. Whether mindfulness-guided therapy can be a new direction for the rehabilitation of patients with Parkinson's disease: a network meta-analysis of non-pharmacological alternative motor-/sensory-based interventions. Front Psychol. 2023 Sep 14;14:1162574. doi: 10.3389/fpsyg.2023.1162574. eCollection 2023.

    PMID: 37780170BACKGROUND
  • Hausdorff JM, Buchman AS. What links gait speed and MCI with dementia? A fresh look at the association between motor and cognitive function. J Gerontol A Biol Sci Med Sci. 2013 Apr;68(4):409-11. doi: 10.1093/gerona/glt002. Epub 2013 Feb 11. No abstract available.

    PMID: 23401565BACKGROUND
  • Gomez Bernal A, Becerro-de-Bengoa-Vallejo R, Losa-Iglesias ME. Reliability of the OptoGait portable photoelectric cell system for the quantification of spatial-temporal parameters of gait in young adults. Gait Posture. 2016 Oct;50:196-200. doi: 10.1016/j.gaitpost.2016.08.035. Epub 2016 Sep 13.

    PMID: 27644096BACKGROUND
  • Giridharan S, Soumian S, Kumar NV, Godbole M. The Impact of Vipassana Meditation on Health and Well-Being: A Systematic Review of Current Evidence. Cureus. 2025 Sep 27;17(9):e93355. doi: 10.7759/cureus.93355. eCollection 2025 Sep.

    PMID: 41158896BACKGROUND
  • Drahota A, Udell JE, Mackenzie H, Pugh MT. Psychological and educational interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2024 Oct 3;10(10):CD013480. doi: 10.1002/14651858.CD013480.pub2.

    PMID: 39360568BACKGROUND
  • Deligianni F, Guo Y, Yang GZ. From Emotions to Mood Disorders: A Survey on Gait Analysis Methodology. IEEE J Biomed Health Inform. 2019 Nov;23(6):2302-2316. doi: 10.1109/JBHI.2019.2938111. Epub 2019 Sep 9.

    PMID: 31502995BACKGROUND
  • Churchill R, Swartz B, Johnston-Dumerauf A, Halaris A. The Impact of Mindfulness-Based Interventions on Objective Physiological Measures of Autonomic Function for Individuals With Medical Conditions: A Review of the Evidence. Psychosom Med. 2024 Jan 1;86(1):2-10. doi: 10.1097/PSY.0000000000001260. Epub 2023 Nov 13.

    PMID: 37982538BACKGROUND
  • Blasche G, deBloom J, Chang A, Pichlhoefer O. Is a meditation retreat the better vacation? effect of retreats and vacations on fatigue, emotional well-being, and acting with awareness. PLoS One. 2021 Feb 8;16(2):e0246038. doi: 10.1371/journal.pone.0246038. eCollection 2021.

    PMID: 33556137BACKGROUND
  • Naranjo JR, Schmidt S. Is it me or not me? Modulation of perceptual-motor awareness and visuomotor performance by mindfulness meditation. BMC Neurosci. 2012 Jul 30;13:88. doi: 10.1186/1471-2202-13-88.

    PMID: 22846109BACKGROUND

MeSH Terms

Interventions

Meditation

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsSpiritual TherapiesRelaxation TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 21, 2026

First Posted

July 31, 2026

Study Start

July 18, 2023

Primary Completion

July 23, 2023

Study Completion

July 23, 2023

Last Updated

July 31, 2026

Record last verified: 2026-07

Locations